Implants News and Research

RSS

MRG's new report on the European markets for small-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.

4 Nov 2009

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Marking a significant bench to bedside research milestone in Singapore, the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, and the National University Hospital (NUH) launched the IBN iCare and the NUH Eye Centre @ Biopolis at an official opening ceremony officiated by the Senior Minister of State for Trade and Industry and Education, S. Iswaran, at the Biopolis on Nov. 3, 2009.

4 Nov 2009

Tumor-penetrating microparticles may offer treatment hope for those suffering with pancreatic cancer

Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.

3 Nov 2009

NuPathe and SurModics sign a drug delivery technology license agreement

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.

3 Nov 2009

Stryker adopts quarterly dividend payment policy

Stryker Corporation announced today that its Board of Directors has modified its dividend policy to adopt a quarterly payment schedule in lieu of an annual dividend. In conjunction with this modification, the Company's Board of Directors has declared a cash transition dividend of $0.10 per share, payable December 16, 2009, to shareholders of record at the close of business on November 18, 2009.

From Stryker 30 Oct 2009

PEM scanners outperform MRI in detecting breast cancer

An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions.

30 Oct 2009

CryoLife reports a net income of $1.9 million for the third quarter of 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the third quarter of 2009 increased 5 percent to a quarterly record of $28.2 million compared to $26.8 million for the third quarter of 2008.

29 Oct 2009

World’s first Cesium-131 lung implants performed

IsoRay, Inc. announced today that starting on August 12, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, and Dr. Nasser Altorki of the Department of Cardiothoracic Surgery at Weill Cornell Medical Center performed the world’s first Cesium-131 lung implants.

29 Oct 2009

Drug delivery device companies need to rethink their strategies to remain competitive

With increasing decentralization, new cell, gene and RNAI therapies, and a growing emphasis on patient self-care, many drug delivery device companies will need to rethink their strategies in order to remain competitive.

29 Oct 2009

Avon Foundation for Women awards grant to improve reconstructive breast surgery

The Avon Foundation for Women has awarded the Clemson University Institute for Biological Interfaces of Engineering a $195,000 grant to support research to develop new ways to improve reconstructive breast surgery using engineered tissue that contains anti-cancer properties.

29 Oct 2009

DSM Biomedical announces new non-biofouling coating technology for medical applications

DSM Biomedical, a global leader in biomedical materials, today announced the development of VitroStealth™, a breakthrough non-biofouling (NBF) coating technology. Specifically developed to combine state of the art non-biofouling properties with high durability and fast processing, VitroStealth™ coating is scratch resistant and reduces unwanted protein absorption and cellular adhesion on surfaces.

28 Oct 2009

RTI Biologics revenues increases to $42.8 million in third quarter 2009

RTI Biologics Inc., a leading processor of orthopedic and other biologic implants, reported operating results for the third quarter ended Sept. 30, 2009.

28 Oct 2009

Rennes University Hospital surgeons undergo training for the SynCardia CardioWest Total Artificial Heart

On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.

28 Oct 2009

Video capsule endoscopy is safe for patients with heart devices

A new Mayo Clinic study suggests that video capsule endoscopy (CE), a procedure that uses wireless technology in diagnosing intestinal disease, is safe for patients with heart devices. Wireless electrical gadgets, such as cell phones, have been shown to interfere with implanted heart devices, including pacemakers and defibrillators. This risk has led medical experts to speculate that capsule endoscopy could similarly cause heart devices to fail.

27 Oct 2009

Ziehm NaviPort interface and BrainLAB Fluoro 3D surgical navigation software improves surgical procedures

Ziehm Imaging and BrainLAB have extended their cooperation to assist surgeons in the intra-operative guidance of pedicle screw and hardware placement during surgical trauma and spinal instrumentation procedures.

27 Oct 2009

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement”) with MAST BioSurgery Inc. (“MAST”) for the development of one or more new surgical products incorporating Ceragenix’s CeraShield™ antimicrobial technology.

26 Oct 2009

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Researchers from Allegheny General Hospital's (AGH) Department of Orthopaedic Surgery and Center for Genomic Sciences have launched dual groundbreaking studies that may help determine the cause of two common, hard-to-treat problems experienced by patients who undergo orthopedic surgery: a joint replacement that becomes infected and a bone fracture that will not heal properly.

24 Oct 2009

Angiotech Pharmaceuticals launches the Tan EndoGlide Endothelium Insertion System in the U.S.

Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.

24 Oct 2009

Axis Three launches 3D surgical simulation platform at Plastic Surgery 2009

At Plastic Surgery 2009, Axis Three (www.axisthree.com), the leader and pioneer of 3D surgical simulation tools for the cosmetic surgery industry, today introduced its Portrait 3D Face Simulation Module, the Company’s latest innovation in its 3D surgical simulation technology.

24 Oct 2009

Javelin MIS Locking Facet System for lumbar spine stabilization

US Spine® announced today that it has launched its Javelin MIS Locking Facet System, designed to stabilize the lumbar spine by locking the facet joints through a minimally invasive incision.

22 Oct 2009

Implants News and Research

MRG's new report on the European markets for small-joint reconstructive implants

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Tumor-penetrating microparticles may offer treatment hope for those suffering with pancreatic cancer

NuPathe and SurModics sign a drug delivery technology license agreement

Stryker adopts quarterly dividend payment policy

PEM scanners outperform MRI in detecting breast cancer

CryoLife reports a net income of $1.9 million for the third quarter of 2009

World’s first Cesium-131 lung implants performed

Drug delivery device companies need to rethink their strategies to remain competitive

Avon Foundation for Women awards grant to improve reconstructive breast surgery

DSM Biomedical announces new non-biofouling coating technology for medical applications

RTI Biologics revenues increases to $42.8 million in third quarter 2009

Rennes University Hospital surgeons undergo training for the SynCardia CardioWest Total Artificial Heart

Video capsule endoscopy is safe for patients with heart devices

Ziehm NaviPort interface and BrainLAB Fluoro 3D surgical navigation software improves surgical procedures

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Angiotech Pharmaceuticals launches the Tan EndoGlide Endothelium Insertion System in the U.S.

Axis Three launches 3D surgical simulation platform at Plastic Surgery 2009

Javelin MIS Locking Facet System for lumbar spine stabilization

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News